Altrinsic Global Advisors’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-37,698
| Closed | -$5.16M | – | 46 |
|
|
2025
Q1 | $5.16M | Sell |
37,698
-2,026
| -5% | -$290K | 0.25% | 37 |
|
|
2024
Q4 | $6.07M | Buy |
39,724
+374
| +1% | +$63.1K | 0.29% | 36 |
|
|
2024
Q3 | $7.63M | Sell |
39,350
-1,092
| -3% | -$228K | 0.32% | 36 |
|
|
2024
Q2 | $9.38M | Sell |
40,442
-1,597
| -4% | -$347K | 0.42% | 32 |
|
|
2024
Q1 | $9.06M | Sell |
42,039
-2,512
| -6% | -$588K | 0.41% | 33 |
|
|
2023
Q4 | $11.5M | Sell |
44,551
-2,610
| -6% | -$641K | 0.49% | 28 |
|
|
2023
Q3 | $12.1M | Sell |
47,161
-2,414
| -5% | -$646K | 0.47% | 31 |
|
|
2023
Q2 | $14.1M | Sell |
49,575
-2,201
| -4% | -$655K | 0.54% | 31 |
|
|
2023
Q1 | $14.4M | Buy |
51,776
+12,449
| +32% | +$3.44M | 0.56% | 31 |
|
|
2022
Q4 | $10.9M | Sell |
39,327
-1,920
| -5% | -$542K | 0.47% | 32 |
|
|
2022
Q3 | $11M | Sell |
41,247
-26,518
| -39% | -$5.63M | 0.51% | 32 |
|
|
2022
Q2 | $13.8M | Sell |
67,765
-4,053
| -6% | -$829K | 0.56% | 31 |
|
|
2022
Q1 | $15.1M | Sell |
71,818
-40,265
| -36% | -$8.76M | 0.53% | 33 |
|
|
2021
Q4 | $26.9M | Sell |
112,083
-13,938
| -11% | -$3.58M | 0.86% | 27 |
|
|
2021
Q3 | $35.7M | Buy |
126,021
+1,168
| +0.9% | +$383K | 1.07% | 26 |
|
|
2021
Q2 | $43.2M | Sell |
124,853
-1,451
| -1% | -$440K | 1.32% | 24 |
|
|
2021
Q1 | $35.3M | Sell |
126,304
-2,507
| -2% | -$676K | 1.11% | 28 |
|
|
2020
Q4 | $31.5M | Buy |
128,811
+6,102
| +5% | +$1.57M | 1.07% | 27 |
|
|
2020
Q3 | $34.8M | Sell |
122,709
-6,634
| -5% | -$1.85M | 1.43% | 23 |
|
|
2020
Q2 | $34.6M | Buy |
129,343
+5,887
| +5% | +$1.77M | 1.51% | 22 |
|
|
2020
Q1 | $39.1M | Sell |
123,456
-12,488
| -9% | -$3.79M | 2.15% | 15 |
|
|
2019
Q4 | $40.3M | Sell |
135,944
-15,336
| -10% | -$4.26M | 1.69% | 19 |
|
|
2019
Q3 | $35.2M | Buy |
151,280
+14,993
| +11% | +$3.49M | 1.53% | 19 |
|
|
2019
Q2 | $31.9M | Buy |
136,287
+28,202
| +26% | +$6.51M | 1.48% | 17 |
|
|
2019
Q1 | $25.5M | Buy |
108,085
+14,458
| +15% | +$4.55M | 1.18% | 27 |
|
|
2018
Q4 | $28.2M | Buy |
93,627
+11,410
| +14% | +$3.64M | 1.35% | 24 |
|
|
2018
Q3 | $29M | Sell |
82,217
-16,218
| -16% | -$5.58M | 1.32% | 26 |
|
|
2018
Q2 | $28.6M | Buy |
98,435
+32,293
| +49% | +$9.08M | 1.13% | 32 |
|
|
2018
Q1 | $18.1M | Sell |
66,142
-25,979
| -28% | -$8.06M | 0.73% | 37 |
|
|
2017
Q4 | $29.3M | Sell |
92,121
-23,769
| -21% | -$7.63M | 1.13% | 27 |
|
|
2017
Q3 | $36.3M | Sell |
115,890
-219
| -0.2% | -$64.8K | 1.37% | 21 |
|
|
2017
Q2 | $31.5M | Sell |
116,109
-2,018
| -2% | -$534K | 1.14% | 26 |
|
|
2017
Q1 | $32.3M | Buy |
118,127
+18,673
| +19% | +$5.28M | 1.1% | 30 |
|
|
2016
Q4 | $28.2M | Sell |
99,454
-13,134
| -12% | -$3.89M | 1.05% | 33 |
|
|
2016
Q3 | $35.2M | Sell |
112,588
-38,196
| -25% | -$11.3M | 1.29% | 27 |
|
|
2016
Q2 | $36.5M | Buy |
150,784
+39,519
| +36% | +$10.4M | 1.03% | 34 |
|
|
2016
Q1 | $29M | Buy |
+111,265
| New | +$29.4M | 0.81% | 42 |
|
Other funds holding BIIB
Altrinsic Global Advisors's BIIB Position: Q2 2025 in Review
Altrinsic Global Advisors sold out of Biogen (BIIB) in Q2 2025, closing a stake of 37,698 shares — an estimated $5.16M sold.
Altrinsic Global Advisors first reported a position in BIIB in Q1 2016 and held it in 37 quarters. The position peaked at $43.2M in Q2 2021. 866 funds tracked by Wall St. Rank hold BIIB as of Q2 2025.
- Altrinsic Global Advisors reported no remaining Biogen position as of Q2 2025 after selling out during the quarter.
- Altrinsic Global Advisors sold 37,698 Biogen shares in Q2 2025, an estimated $5.16M.
- Altrinsic Global Advisors first reported a position in Biogen in Q1 2016 and held it in 37 quarters.
- Altrinsic Global Advisors's Biogen position peaked at $43.2M in Q2 2021.
- 866 funds tracked by Wall St. Rank held Biogen as of Q2 2025.
Based on Altrinsic Global Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.